Mauro Martins Teixeira Selected Research

Acetaminophen (Paracetamol)

12/2018	Paradoxical Role of Matrix Metalloproteinases in Liver Injury and Regeneration after Sterile Acute Hepatic Failure.
1/2018	SOCS2 Is Critical for the Balancing of Immune Response and Oxidate Stress Protecting Against Acetaminophen-Induced Acute Liver Injury.
1/2015	Hepatic DNA deposition drives drug-induced liver injury and inflammation in mice.
1/2014	Interleukin-4 deficiency protects mice from acetaminophen-induced liver injury and inflammation by prevention of glutathione depletion.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mauro Martins Teixeira Research Topics

Disease

62	Inflammation (Inflammations) 04/2024 - 03/2007
57	Infections 01/2024 - 08/2004
14	Arthritis (Polyarthritis) 01/2024 - 08/2004
11	Pneumonia (Pneumonitis) 01/2024 - 01/2013
10	Neoplasms (Cancer) 01/2024 - 02/2010
9	Fibrosis (Cirrhosis) 02/2023 - 04/2007
9	Chagas Disease (American Trypanosomiasis) 11/2021 - 04/2007
8	COVID-19 10/2023 - 01/2021
8	Necrosis 01/2020 - 09/2009
7	Obesity 03/2024 - 02/2016
6	Virus Diseases (Viral Diseases) 12/2023 - 07/2010
6	Ischemia 11/2022 - 07/2008
6	Bone Resorption 03/2016 - 01/2010
5	Zika Virus Infection 12/2023 - 01/2017
5	Gout 10/2022 - 08/2015
4	Glucose Intolerance 03/2024 - 01/2014
4	Dengue (Dengue Fever) 02/2024 - 09/2013
4	Leprosy (Hansen's Disease) 01/2024 - 01/2008
4	Graft vs Host Disease (Graft-Versus-Host Disease) 10/2023 - 11/2017
4	Alveolar Bone Loss 04/2023 - 10/2011
4	Reperfusion Injury 08/2022 - 07/2008
4	Mucositis 08/2022 - 05/2012
4	Communicable Diseases (Infectious Diseases) 01/2022 - 12/2013
4	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2022 - 03/2016
4	Brain Ischemia (Cerebral Ischemia) 01/2017 - 01/2013
4	Parasitemia 05/2016 - 08/2010
4	Periodontal Diseases (Periodontal Disease) 11/2014 - 01/2012
3	Neuroinflammatory Diseases 12/2023 - 01/2019
3	Weight Loss (Weight Reduction) 10/2023 - 01/2016
3	Insulin Resistance 01/2023 - 06/2014
3	Fatigue 01/2021 - 04/2013
3	Asthma (Bronchial Asthma) 01/2021 - 01/2020
3	Disease Progression 01/2021 - 07/2012
3	Silicosis 12/2019 - 05/2014
3	Chemical and Drug Induced Liver Injury 12/2019 - 01/2015
3	Cerebral Malaria 11/2017 - 01/2015
3	Chronic Renal Insufficiency 04/2017 - 07/2011
3	Ischemic Stroke 01/2017 - 01/2013
3	Sepsis (Septicemia) 01/2016 - 01/2015
3	Herpes Simplex Encephalitis (Herpes Encephalitis) 02/2013 - 11/2008

Drug/Important Bio-Agent (IBA)

41	CytokinesIBA 03/2024 - 01/2008
22	ChemokinesIBA 01/2024 - 08/2004
14	AntigensIBA 01/2023 - 07/2012
12	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2024 - 09/2009
12	Proteins (Proteins, Gene)FDA Link 11/2023 - 01/2012
11	angiotensin I (1-7)IBA 04/2024 - 04/2007
10	Interleukin-6 (Interleukin 6)IBA 01/2024 - 04/2012
9	Messenger RNA (mRNA)IBA 01/2024 - 03/2007
8	CollagenIBA 01/2021 - 08/2010
7	Annexin A1IBA 11/2023 - 01/2016
7	InterleukinsIBA 10/2023 - 05/2014
7	Biomarkers (Surrogate Marker)IBA 01/2023 - 02/2010
6	VaccinesIBA 02/2024 - 09/2015
6	Antiviral Agents (Antivirals)IBA 01/2023 - 01/2021
6	Peptides (Polypeptides)IBA 08/2022 - 08/2015
5	DNA (Deoxyribonucleic Acid)IBA 08/2022 - 01/2015
5	Interferon-gamma (Interferon, gamma)IBA 12/2021 - 08/2014
5	platelet activating factor receptorIBA 01/2020 - 01/2013
5	Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA 01/2020 - 08/2010
5	EnzymesIBA 07/2018 - 08/2010
5	Interleukin-17 (Interleukin 17)IBA 01/2018 - 01/2012
5	Platelet Activating FactorIBA 12/2016 - 01/2013
4	OvalbuminIBA 04/2024 - 02/2016
4	Glucose (Dextrose)FDA LinkGeneric 03/2024 - 06/2014
4	LigandsIBA 01/2024 - 09/2009
4	Immunoglobulin G (IgG)IBA 01/2023 - 01/2014
4	Monoclonal AntibodiesIBA 01/2023 - 01/2015
4	CarbohydratesIBA 01/2023 - 09/2015
4	Interleukin-12 (IL 12)IBA 10/2021 - 01/2010
4	Caspase 3 (Caspase-3)IBA 01/2021 - 04/2012
4	Interleukin-10 (Interleukin 10)IBA 01/2020 - 05/2014
4	Acetaminophen (Paracetamol)FDA LinkGeneric 12/2018 - 01/2014
4	CC ChemokinesIBA 01/2017 - 09/2004
4	Chemokine CCL5IBA 02/2009 - 08/2004
3	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2024 - 01/2014
3	Chemotactic FactorsIBA 01/2024 - 01/2017
3	zileuton (Zyflo)FDA Link 10/2023 - 01/2015
3	Ethanol (Ethyl Alcohol)IBA 01/2023 - 03/2016
3	phycocyanobilinIBA 01/2023 - 02/2018
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2023 - 05/2016
3	Immunoglobulin M (IgM)IBA 01/2023 - 09/2013
3	Interleukin-4 (Interleukin 4)IBA 01/2023 - 01/2014
3	PhycocyaninIBA 01/2023 - 03/2016
3	Uric Acid (Urate)IBA 10/2022 - 08/2015
3	AntioxidantsIBA 05/2021 - 03/2016
3	Oxygen (Dioxygen)IBA 05/2021 - 07/2008
3	InterferonsIBA 01/2020 - 02/2011
3	Type I Tumor Necrosis Factor ReceptorsIBA 01/2018 - 07/2010
3	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2018 - 02/2011
3	Leukotriene B4IBA 11/2017 - 08/2004
3	LipidsIBA 01/2017 - 08/2010
3	Chemokine ReceptorsIBA 05/2016 - 07/2010
3	AutoantibodiesIBA 11/2010 - 04/2007
3	Met- RANTESIBA 02/2009 - 09/2004

Therapy/Procedure

26	Therapeutics 01/2024 - 07/2008
5	Drug Therapy (Chemotherapy) 08/2022 - 02/2010
4	Oral Administration 01/2021 - 02/2018
3	Euthanasia (Mercy Killing) 11/2023 - 01/2021
3	Liver Transplantation 08/2022 - 01/2017
3	Aftercare (After-Treatment) 01/2019 - 02/2010